Back


05/02/2017
IMCHECK THERAPEUTICS RAISES €20 MILLION AND APPOINTS ITS CEO
ImCheck Therapeutics, an emerging player in the field of cancer and auto-immunity, today announced the completion of a €20 Million Series A financing round led by Boehringer Ingelheim Venture Fund (BIVF), Kurma Partners, Idinvest and joined by Gimv [...]




X

X